Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Chronic Heart Failure

Free Subscription Articles published in J Am Coll Cardiol Retrieve available abstracts of 270 articles: HTML format

Single Articles

March 2023
1. DISMORR M, Glaser N, Franco-Cereceda A, Sartipy U, et al
   Effect of Prosthesis-Patient Mismatch on Long-Term Clinical Outcomes After Bioprosthetic Aortic Valve Replacement.
   J Am Coll Cardiol. 2023;81:964-975.
   PubMed     Abstract available
   
   
   
2. VADUGANATHAN M, Claggett BL, Jhund P, Miao ZM, et al
   Dapagliflozin and All-Cause Hospitalizations in Patients With Heart Failure With Preserved Ejection Fraction.
   J Am Coll Cardiol. 2023;81:1004-1006.
   PubMed    
   
   
   
3. LAZARO I, Lupon J, Cediel G, Sala-Vila A, et al
   Reply: Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
   J Am Coll Cardiol. 2023;81:e69.
   PubMed    
   
   
   
4. WU J, Liang J, Huang Y
   Circulating Vegetable Omega-3 and Prognosis in Patients With Heart Failure: More Data Are Needed.
   J Am Coll Cardiol. 2023;81:e67.
   PubMed    
   
   
   
5. MENASCHE P
   Mesenchymal Stromal Cell Therapy for Heart Failure: Never Stop DREAMing.
   J Am Coll Cardiol. 2023;81:864-866.
   PubMed    
   
   
   
6. PERIN EC, Borow KM, Henry TD, Mendelsohn FO, et al
   Randomized Trial of Targeted Transendocardial Mesenchymal Precursor Cell Therapy in Patients With Heart Failure.
   J Am Coll Cardiol. 2023;81:849-863.
   PubMed     Abstract available
   
   
   February 2023
7. WECKBACH LT, Stolz L, Chatfield AG, Fam NP, et al
   Right Ventricular Reverse Remodeling After Transcatheter Tricuspid Valve Replacement in Patients With Heart Failure.
   J Am Coll Cardiol. 2023;81:708-710.
   PubMed    
   
   
   
8. BHATT AS, Varshney AS, Moscone A, Claggett BL, et al
   Virtual Care Team-Guided Therapeutic Optimization During Hospitalization in Patients with Heart Failure: The IMPLEMENT-HF Study.
   J Am Coll Cardiol. 2023 Feb 21:S0735-1097(23)04471.
   PubMed     Abstract available
   
   
   
9. CHATUR S, Claggett BL, McCausland FR, Rouleau J, et al
   Variation in Renal Function Following Transition to Sacubitril/Valsartan in Patients with Heart Failure.
   J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00335.
   PubMed     Abstract available
   
   
   
10. MUKHOPADHYAY A, Reynolds HR, Phillips LM, Nagler AR, et al
    Cluster-Randomized Trial Comparing Ambulatory Decision Support Tools to Improve Heart Failure Care.
    J Am Coll Cardiol. 2023 Feb 9:S0735-1097(23)00329.
    PubMed     Abstract available
    
    
    
11. WEINTRAUB WS
    Improving the Quality of Life for Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2023;81:474-476.
    PubMed    
    
    
    
12. KOSIBOROD MN, Bhatt AS, Claggett BL, Vaduganathan M, et al
    Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection Fraction.
    J Am Coll Cardiol. 2023;81:460-473.
    PubMed     Abstract available
    
    
    January 2023
13. GREENE SJ, Bauersachs J, Brugts JJ, Ezekowitz JA, et al
    Worsening Heart Failure: Nomenclature, Epidemiology, and Future Directions: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2023;81:413-424.
    PubMed     Abstract available
    
    
    
14. PAGE RL 2ND
    The Real-World Price of Switching to an ARNI: A Case for De Novo Sacubitril/Valsartan Initiation.
    J Am Coll Cardiol. 2023;81:332-335.
    PubMed    
    
    
    
15. KHAN MS, Shahid I, Anker SD, Fonarow GC, et al
    Albuminuria and Heart Failure: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2023;81:270-282.
    PubMed     Abstract available
    
    
    
16. MENTIAS A, Smedira NG, Krishnaswamy A, Reed GW, et al
    Survival After Septal Reduction in Patients >65 Years Old With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:105-115.
    PubMed     Abstract available
    
    
    
17. MARON MS, Masri A, Choudhury L, Olivotto I, et al
    Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2023;81:34-45.
    PubMed     Abstract available
    
    
    December 2022
18. LAI FTT, Chan EWW, Huang L, Cheung CL, et al
    Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.
    J Am Coll Cardiol. 2022;80:2255-2265.
    PubMed     Abstract available
    
    
    
19. MOORE JP, Marelli A, Burchill LJ, Chubb H, et al
    Management of Heart Failure With Arrhythmia in Adults With Congenital Heart Disease: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2224-2238.
    PubMed     Abstract available
    
    
    
20. MA H, Wang X, Li X, Heianza Y, et al
    Adding Salt to Foods and Risk of Cardiovascular Disease.
    J Am Coll Cardiol. 2022;80:2157-2167.
    PubMed     Abstract available
    
    
    November 2022
21. CHANG YK, McClung JA, Allen LA, Philip J, et al
    Reply: Early Integration of Specialist Palliative Care in Advanced Heart Failure: A Multipronged Approach.
    J Am Coll Cardiol. 2022;80:e205-e206.
    PubMed    
    
    
    
22. AREVALO LORIDO JC, Salamanca Bautista P, Formiga F, Mendez Bailon M, et al
    Tackling Palliative Care in Advanced Heart Failure.
    J Am Coll Cardiol. 2022;80:e203-e204.
    PubMed    
    
    
    
23. RICKETTI DA, Krickus CL
    Strain on Palliative Care Services May Limit Resources for Advanced Heart Failure Patients.
    J Am Coll Cardiol. 2022;80:e201.
    PubMed    
    
    
    
24. PAHUJA M, Johnson A, Kabir R, Bhogal S, et al
    Randomized Trials of Percutaneous Microaxial Flow Pump Devices: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:2028-2049.
    PubMed     Abstract available
    
    
    
25. SCHINDLER TH, Valenta I, Dilsizian V
    Disturbances in Brain-Heart Neuronal-Metabolic Axis Are Associated With Major Arrhythmic Events in Heart Failure.
    J Am Coll Cardiol. 2022;80:1897-1899.
    PubMed    
    
    
    
26. BAI Y, Yun M, Nie B, Shan L, et al
    Neurometabolism and Ventricular Dyssynchrony in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1884-1896.
    PubMed     Abstract available
    
    
    
27. GIUSTINO G, Camaj A, Kapadia SR, Kar S, et al
    Hospitalizations and Mortality in Patients With Secondary Mitral Regurgitation and Heart Failure: The COAPT Trial.
    J Am Coll Cardiol. 2022;80:1857-1868.
    PubMed     Abstract available
    
    
    
28. NASSIF ME, Januzzi JL Jr
    Implementing Sodium-Glucose Cotransporter-2 Inhibitor Therapy for Heart Failure: What Is the Message to DELIVER?
    J Am Coll Cardiol. 2022;80:1785-1787.
    PubMed    
    
    
    
29. VADUGANATHAN M, Claggett BL, Jhund P, de Boer RA, et al
    Estimated Long-Term Benefit of Dapagliflozin in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1775-1784.
    PubMed     Abstract available
    
    
    
30. AL-MOHAMMAD A
    Circulating Plant-Based Omega-3 in Heart Failure: A Prognostic Marker or a Therapeutic Target?
    J Am Coll Cardiol. 2022;80:1759-1761.
    PubMed    
    
    
    
31. LAZARO I, Lupon J, Cediel G, Codina P, et al
    Relationship of Circulating Vegetable Omega-3 to Prognosis in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:1751-1758.
    PubMed     Abstract available
    
    
    
32. ZANNAD F
    Heart Failure and Kidney Disease in Type 2 Diabetes: 2 Sides of the Same Coin.
    J Am Coll Cardiol. 2022;80:1732-1734.
    PubMed    
    
    
    
33. SARRAJU A, Bakris G, Cannon CP, Cherney D, et al
    Cardiovascular Effects of Canagliflozin in Relation to Renal Function and Albuminuria.
    J Am Coll Cardiol. 2022;80:1721-1731.
    PubMed     Abstract available
    
    
    October 2022
34. SALAH HM, Goldberg LR, Molinger J, Felker GM, et al
    Diaphragmatic Function in Cardiovascular Disease: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;80:1647-1659.
    PubMed     Abstract available
    
    
    
35. MOHEBI R, Liu Y, Pina IL, Prescott MF, et al
    Dose-Response to Sacubitril/Valsartan in Patients With Heart Failure and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;80:1529-1541.
    PubMed     Abstract available
    
    
    
36. WALSH MN
    Guideline-Directed Medical Therapy: Even a Little Is Better Than None.
    J Am Coll Cardiol. 2022;80:1542-1544.
    PubMed    
    
    
    
37. ASCHER SB, de Lemos JA, Lee M, Wu E, et al
    Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
    J Am Coll Cardiol. 2022;80:1516-1525.
    PubMed     Abstract available
    
    
    
38. JANUSZEWICZ A, Mulatero P, Dobrowolski P, Monticone S, et al
    Cardiac Phenotypes in Secondary Hypertension: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;80:1480-1497.
    PubMed     Abstract available
    
    
    
39. SAVVATIS K, Vissing CR, Klouvi L, Florian A, et al
    Cardiac Outcomes in Adults With Mitochondrial Diseases.
    J Am Coll Cardiol. 2022;80:1421-1430.
    PubMed     Abstract available
    
    
    
40. DE FRUTOS F, Ochoa JP, Navarro-Penalver M, Baas A, et al
    Natural History of MYH7-Related Dilated Cardiomyopathy.
    J Am Coll Cardiol. 2022;80:1447-1461.
    PubMed     Abstract available
    
    
    
41. D'ALESSANDRO DA, Wolfe SB, Osho AA, Drezek K, et al
    Hemodynamic and Clinical Performance of Hearts Donated After Circulatory Death.
    J Am Coll Cardiol. 2022;80:1314-1326.
    PubMed     Abstract available
    
    
    September 2022
42. VIJAYARAMAN P, Batul SA
    Left Bundle Branch Pacing for Cardiac Resynchronization: Are We Ready for a Leap of Faith?
    J Am Coll Cardiol. 2022;80:1217-1219.
    PubMed    
    
    
    
43. WANG Y, Zhu H, Hou X, Wang Z, et al
    Randomized Trial of Left Bundle Branch vs Biventricular Pacing for Cardiac Resynchronization Therapy.
    J Am Coll Cardiol. 2022;80:1205-1216.
    PubMed     Abstract available
    
    
    
44. KARAMLOU T, Devlin PJ, Hammoud MS
    Late Systemic Right Ventricle Failure: Moving Toward a Real-Time Prediction Tool.
    J Am Coll Cardiol. 2022;80:964-966.
    PubMed    
    
    
    
45. BROBERG CS, van Dissel A, Minnier J, Aboulhosn J, et al
    Long-Term Outcomes After Atrial Switch Operation for Transposition of the Great Arteries.
    J Am Coll Cardiol. 2022;80:951-963.
    PubMed     Abstract available
    
    
    August 2022
46. IDRISS SF, Weiland MD
    Ventricular Pacing in Single Ventricle Circulation: Making the Best of a Difficult Situation.
    J Am Coll Cardiol. 2022;80:915-917.
    PubMed    
    
    
    
47. BUTT JH, Dewan P, Jhund PS, Anand IS, et al
    Sacubitril/Valsartan and Frailty in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05596.
    PubMed     Abstract available
    
    
    
48. AHMAD T, Desai NR, Velazquez EJ
    SGLT2 Inhibitors Should Be Considered for All Patients With Heart Failure.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05770.
    PubMed    
    
    
    
49. CUNNINGHAM JW, Vaduganathan M, Claggett BL, Kulac IJ, et al
    Dapagliflozin in Patients Recently Hospitalized With Heart Failure and Mildly Reduced or Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022 Aug 26. pii: S0735-1097(22)05673.
    PubMed     Abstract available
    
    
    
50. LA GERCHE A, Howden EJ, Haykowsky MJ, Lewis GD, et al
    Heart Failure With Preserved Ejection Fraction as an Exercise Deficiency Syndrome: JACC Focus Seminar 2/4.
    J Am Coll Cardiol. 2022 Aug 24. pii: S0735-1097(22)05603.
    PubMed     Abstract available
    
    
    
51. LAU ES, Ho JE
    Reply: Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e61-e62.
    PubMed    
    
    
    
52. MARTINEZ-SELLES M
    Previous Pregnancies and Heart Failure Prognosis.
    J Am Coll Cardiol. 2022;80:e59.
    PubMed    
    
    
    
53. CORBALAN R, Acevedo M
    Glifozins and Atrial Fibrillation.
    J Am Coll Cardiol. 2022 Aug 23. pii: S0735-1097(22)06612.
    PubMed    
    
    
    
54. BUTT JH, Kondo T, Jhund PS, Comin-Colet J, et al
    Dapagliflozin, atrial fibrillation, and heart failure with mildly reduced or preserved ejection fraction in DELIVER.
    J Am Coll Cardiol. 2022 Aug 13. pii: S0735-1097(22)06529.
    PubMed     Abstract available
    
    
    
55. HECKMAN GA, Rockwood K
    Frailty, Risk, and Heart Failure Care: Commission or Omission?
    J Am Coll Cardiol. 2022 Aug 12. pii: S0735-1097(22)05597.
    PubMed    
    
    
    
56. BOCCHI EA, Lima IGCV
    The Challenge of Reducing Complexity of Heart Failure Treatment Without Losing Efficacy: Quo Vadis?
    J Am Coll Cardiol. 2022;80:595-597.
    PubMed    
    
    
    
57. YE F, Wang X, Wu S, Ma S, et al
    Sustained-Release Ivabradine Hemisulfate in Patients With Systolic Heart Failure.
    J Am Coll Cardiol. 2022;80:584-594.
    PubMed     Abstract available
    
    
    
58. MOHEBI R, Chen C, Ibrahim NE, McCarthy CP, et al
    Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates.
    J Am Coll Cardiol. 2022;80:565-578.
    PubMed     Abstract available
    
    
    
59. WILEY BM, Borlaug BA, Kane GC
    Lung Ultrasound in Heart Failure: Envisioning Handheld Ultrasound to Empower Nurses and Transform Health Care.
    J Am Coll Cardiol. 2022;80:524-526.
    PubMed    
    
    
    
60. ZISIS G, Yang Y, Huynh Q, Whitmore K, et al
    Nurse-Provided Lung and Inferior Vena Cava Assessment in Patients With Heart Failure.
    J Am Coll Cardiol. 2022;80:513-523.
    PubMed     Abstract available
    
    
    July 2022
61. BADRAN S, Lee S
    Even in Heart Failure, Integrating Palliative Care and Aggressive Medical Therapy Is a Thing.
    J Am Coll Cardiol. 2022;80:345-347.
    PubMed    
    
    
    
62. CHANG YK, Allen LA, McClung JA, Denvir MA, et al
    Criteria for Referral of Patients With Advanced Heart Failure for Specialized Palliative Care.
    J Am Coll Cardiol. 2022;80:332-344.
    PubMed     Abstract available
    
    
    
63. KOCHAR A, Smilowitz NR, Hochman JS
    Dynamic Cardiogenic Shock Classification: 2 Steps Forward, 1 Step Back.
    J Am Coll Cardiol. 2022;80:199-201.
    PubMed    
    
    
    
64. KAPUR NK, Kanwar M, Sinha SS, Thayer KL, et al
    Criteria for Defining Stages of Cardiogenic Shock Severity.
    J Am Coll Cardiol. 2022;80:185-198.
    PubMed     Abstract available
    
    
    
65. JANUZZI JL JR, Butler J
    The Importance of Worsening Heart Failure: Hiding in Plain Sight.
    J Am Coll Cardiol. 2022;80:123-125.
    PubMed    
    
    
    
66. AMBROSY AP, Parikh RV, Sung SH, Tan TC, et al
    Analysis of Worsening Heart Failure Events in an Integrated Health Care System.
    J Am Coll Cardiol. 2022;80:111-122.
    PubMed     Abstract available
    
    
    
67. SAUER AJ
    Empagliflozin and Elderly Patients With Preserved Ejection Fraction Heart Failure: Is Age Just a Number?
    J Am Coll Cardiol. 2022;80:19-21.
    PubMed    
    
    
    
68. BOHM M, Butler J, Filippatos G, Ferreira JP, et al
    Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of Age.
    J Am Coll Cardiol. 2022;80:1-18.
    PubMed     Abstract available
    
    
    
69. FLORIDO R, Daya NR, Ndumele CE, Koton S, et al
    Cardiovascular Disease Risk Among Cancer Survivors: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;80:22-32.
    PubMed     Abstract available
    
    
    June 2022
70. WASFY JH, O'Kelly AC
    Value-Based Prices Could Establish Common Ground on Heart Failure Drug Pricing and Coverage.
    J Am Coll Cardiol. 2022;79:2526-2528.
    PubMed    
    
    
    
71. FARIDI KF, Dayoub EJ, Ross JS, Dhruva SS, et al
    Medicare Coverage and Out-of-Pocket Costs of Quadruple Drug Therapy for Heart Failure.
    J Am Coll Cardiol. 2022;79:2516-2525.
    PubMed     Abstract available
    
    
    
72. PRASADA S, Desai MY, Saad M, Smilowitz NR, et al
    Preoperative Atrial Fibrillation and Cardiovascular Outcomes After Noncardiac Surgery.
    J Am Coll Cardiol. 2022;79:2471-2485.
    PubMed     Abstract available
    
    
    
73. BIONDI-ZOCCAI G, Peruzzi M, Frati G
    Is Smoking Cessation the Best Intervention Ever to Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2306-2309.
    PubMed    
    
    
    
74. DING N, Shah AM, Blaha MJ, Chang PP, et al
    Cigarette Smoking, Cessation, and Risk of Heart Failure With Preserved and Reduced Ejection Fraction.
    J Am Coll Cardiol. 2022;79:2298-2305.
    PubMed     Abstract available
    
    
    
75. VERMA S, Pandey A, Bhatt DL
    Forecasting Heart Failure Risk in Diabetes.
    J Am Coll Cardiol. 2022;79:2294-2297.
    PubMed    
    
    
    
76. ECHOUFFO-TCHEUGUI JB, Ndumele CE, Zhang S, Florido R, et al
    Diabetes and Progression of Heart Failure: The Atherosclerosis Risk In Communities (ARIC) Study.
    J Am Coll Cardiol. 2022;79:2285-2293.
    PubMed     Abstract available
    
    
    
77. AJOOLABADY A, Nattel S, Lip GYH, Ren J, et al
    Inflammasome Signaling in Atrial Fibrillation: JACC State-of-the-Art Review.
    J Am Coll Cardiol. 2022;79:2349-2366.
    PubMed     Abstract available
    
    
    May 2022
78. SCHOCKEN DD
    Registry Evidence for Modulation of the Acute Ischemic Heart Disease Pathway: Statins Prevent Heart Failure?
    J Am Coll Cardiol. 2022;79:2034-2036.
    PubMed    
    
    
    
79. BUGIARDINI R, Yoon J, Mendieta G, Kedev S, et al
    Reduced Heart Failure and Mortality in Patients Receiving Statin Therapy Before Initial Acute Coronary Syndrome.
    J Am Coll Cardiol. 2022;79:2021-2033.
    PubMed     Abstract available
    
    
    
80. UDELL JA, Jones WS, Petrie MC, Harrington J, et al
    Sodium Glucose Cotransporter-2 Inhibition for Acute Myocardial Infarction: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:2058-2068.
    PubMed     Abstract available
    
    
    
81. NORRISH G, Cleary A, Field E, Cervi E, et al
    Clinical Features and Natural History of Preadolescent Nonsyndromic Hypertrophic Cardiomyopathy.
    J Am Coll Cardiol. 2022;79:1986-1997.
    PubMed     Abstract available
    
    
    
82. DALY KP, Zuckerman WA
    The Burden of Pediatric Heart Failure That Lies Just Under the Surface.
    J Am Coll Cardiol. 2022;79:1929-1931.
    PubMed    
    
    
    
83. AMDANI S, Marino BS, Rossano J, Lopez R, et al
    Burden of Pediatric Heart Failure in the United States.
    J Am Coll Cardiol. 2022;79:1917-1928.
    PubMed     Abstract available
    
    
    
84. FUDIM M, Kaye DM, Borlaug BA, Shah SJ, et al
    Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1858-1869.
    PubMed     Abstract available
    
    
    April 2022
85. DRIGGIN E, Cohen LP, Gallagher D, Karmally W, et al
    Nutrition Assessment and Dietary Interventions in Heart Failure: JACC Review Topic of the Week.
    J Am Coll Cardiol. 2022;79:1623-1635.
    PubMed     Abstract available
    
    
    
86. DEFILIPPIS EM
    Infertility: A Fertile Ground for Heart Failure?
    J Am Coll Cardiol. 2022;79:1604-1605.
    PubMed    
    
    
    
87. LAU ES, Wang D, Roberts M, Taylor CN, et al
    Infertility and Risk of Heart Failure in the Women's Health Initiative.
    J Am Coll Cardiol. 2022;79:1594-1603.
    PubMed     Abstract available
    
    
    
88. NEGISHI K, Pathan F
    Novel Left Atrial Markers for Risk Stratification of Heart Failure: Ready for Prime Time?
    J Am Coll Cardiol. 2022;79:1562-1564.
    PubMed    
    
    
    
89. INCIARDI RM, Claggett B, Minamisawa M, Shin SH, et al
    Association of Left Atrial Structure and Function With Heart Failure in Older Adults.
    J Am Coll Cardiol. 2022;79:1549-1561.
    PubMed     Abstract available
    
    
    
90. KHAN SS, Beach LB, Yancy CW
    Sex-Based Differences in Heart Failure: JACC Focus Seminar 7/7.
    J Am Coll Cardiol. 2022;79:1530-1541.
    PubMed     Abstract available
    
    
    
91. ARENAL A, Avila P, Jimenez-Candil J, Tercedor L, et al
    Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
    J Am Coll Cardiol. 2022;79:1441-1453.
    PubMed     Abstract available
    
    
    
92. MENTIAS A, Aminian A, Youssef D, Pandey A, et al
    Long-Term Cardiovascular Outcomes After Bariatric Surgery in the Medicare Population.
    J Am Coll Cardiol. 2022;79:1429-1437.
    PubMed     Abstract available
    
    
    
93. LINDLEY KJ, Williams D, Davila-Roman VG
    Reply: When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e243.
    PubMed    
    
    
    
94. SCIATTI E, Orabona R
    When Preclinical Data Meet Epidemiology: Preeclampsia and Future HFpEF.
    J Am Coll Cardiol. 2022;79:e241.
    PubMed    
    
    
    
95. KRIEGER EV, Kim YY
    Lumping vs Splitting in Adult Congenital Heart Disease Research.
    J Am Coll Cardiol. 2022;79:1366-1368.
    PubMed    
    
    
    March 2022
96. FERREIRA JP, Butler J, Zannad F, Filippatos G, et al
    Mineralocorticoid Receptor Antagonists and Empagliflozin in Patients With Heart Failure and Preserved Ejection Fraction.
    J Am Coll Cardiol. 2022;79:1129-1137.
    PubMed     Abstract available
    
    
    
97. VAN SPALL HGC, Fonarow GC, Mamas MA
    Under-utilization of Guideline-Directed Medical Therapy in Heart Failure: Can Digital Health Technologies PROMPT Change?
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(22)04564.
    PubMed    
    
    
    
98. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08394.
    PubMed     Abstract available
    
    
    
99. HEIDENREICH PA, Bozkurt B, Aguilar D, Allen LA, et al
    2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
    J Am Coll Cardiol. 2022 Mar 24. pii: S0735-1097(21)08395.
    PubMed     Abstract available
    
    
    
100. VARSHNEY AS, DeFilippis EM, Cowger JA, Netuka I, et al
     Trends and Outcomes of Left Ventricular Assist Device Therapy: JACC Focus Seminar.
     J Am Coll Cardiol. 2022;79:1092-1107.
     PubMed     Abstract available
     
     
     
101. GHAZI L, Yamamoto Y, Riello RJ, Coronel-Moreno C, et al
     Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
     J Am Coll Cardiol. 2022 Mar 19. pii: S0735-1097(22)04489.
     PubMed     Abstract available
     
     
     
102. PALAU P, Seller J, Dominguez E, Bayes-Genis A, et al
     Reply: Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022;79:e197-e198.
     PubMed    
     
     
     
103. FAUCHIER L, Bodin A, Bisson A
     Beta-Blocker Withdrawal and Chronotropic Incompetence in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2022;79:e195.
     PubMed    
     
     
     
104. JANUZZI JL JR, Ohman EM
     Underdiagnosis of Ischemic Heart Disease in New-Onset Heart Failure: A Call to Action.
     J Am Coll Cardiol. 2022;79:861-863.
     PubMed    
     
     
     
105. ZHENG J, Heidenreich PA, Kohsaka S, Fearon WF, et al
     Variability in Coronary Artery Disease Testing for Patients With New-Onset Heart Failure.
     J Am Coll Cardiol. 2022;79:849-860.
     PubMed     Abstract available
     
     
     
106. TOPKARA VK, Sayer GT, Clerkin KJ, Wever-Pinzon O, et al
     Recovery With Temporary Mechanical Circulatory Support While Waitlisted for Heart Transplantation.
     J Am Coll Cardiol. 2022;79:900-913.
     PubMed     Abstract available
     
     
     
107. JEFFERIES JL, Saffitz JE
     Autophagy and Reverse Remodeling: A New Biomarker in Heart Failure?
     J Am Coll Cardiol. 2022;79:802-804.
     PubMed    
     
     
     
108. KANAMORI H, Yoshida A, Naruse G, Endo S, et al
     Impact of Autophagy on Prognosis of Patients With Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2022;79:789-801.
     PubMed     Abstract available
     
     
     February 2022
109. FIUZAT M, Hamo CE, Butler J, Abraham WT, et al
     Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:504-510.
     PubMed     Abstract available
     
     
     
110. VADUGANATHAN M, Sattar N, Xu J, Butler J, et al
     Stress Cardiac Biomarkers, Cardiovascular and Renal Outcomes, and Response to Canagliflozin.
     J Am Coll Cardiol. 2022;79:432-444.
     PubMed     Abstract available
     
     
     
111. FONTES JD, Massera D
     The Path to Better Understanding Heart Failure Epidemiology.
     J Am Coll Cardiol. 2022;79:369-371.
     PubMed    
     
     
     
112. CHANDRA A, Skali H, Claggett B, Solomon SD, et al
     Race- and Gender-Based Differences in Cardiac Structure and Function and Risk of Heart Failure.
     J Am Coll Cardiol. 2022;79:355-368.
     PubMed     Abstract available
     
     
     
113. MASINI G, Graham FJ, Pellicori P, Cleland JGF, et al
     Criteria for Iron Deficiency in Patients With Heart Failure.
     J Am Coll Cardiol. 2022;79:341-351.
     PubMed     Abstract available
     
     
     
114. COSTANZO MR, Januzzi JL Jr
     21st Century CE: The New Iron Age?
     J Am Coll Cardiol. 2022;79:352-354.
     PubMed    
     
     
     January 2022
115. LOCCOH EC, Joynt Maddox KE, Wang Y, Kazi DS, et al
     Rural-Urban Disparities in Outcomes of Myocardial Infarction, Heart Failure, and Stroke in the United States.
     J Am Coll Cardiol. 2022;79:267-279.
     PubMed     Abstract available
     
     
     
116. WALSH MN
     Change in Lifetime Risk of Heart Failure: Applicable to All?
     J Am Coll Cardiol. 2022;79:264-266.
     PubMed    
     
     
     
117. VASAN RS, Enserro DM, Beiser AS, Xanthakis V, et al
     Lifetime Risk of Heart Failure Among Participants in the Framingham Study.
     J Am Coll Cardiol. 2022;79:250-263.
     PubMed     Abstract available
     
     
     
118. MANTOVANI A, Byrne CD, Benfari G, Bonapace S, et al
     Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2022;79:180-191.
     PubMed     Abstract available
     
     
     
119. VOLGMAN AS, Nair G, Lyubarova R, Merchant FM, et al
     Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2022;79:166-179.
     PubMed     Abstract available
     
     
     
120. BERRY C, Ibanez B
     Intramyocardial Hemorrhage: The Final Frontier for Preventing Heart Failure Post-Myocardial Infarction.
     J Am Coll Cardiol. 2022;79:49-51.
     PubMed    
     
     
     December 2021
121. EMERSON D, Chikwe J, Catarino P, Kobashigawa J, et al
     Reply: Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
     J Am Coll Cardiol. 2021;78:e323.
     PubMed    
     
     
     
122. RODENAS-ALESINA E, Billia F, Rao V, Ross HJ, et al
     Do Elderly Patients With Advanced Heart Failure Have Better Outcomes After LVAD?
     J Am Coll Cardiol. 2021;78:e321.
     PubMed    
     
     
     
123. PINA IL, Jimenez S, Lewis EF, Morris AA, et al
     Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9.
     J Am Coll Cardiol. 2021;78:2589-2598.
     PubMed     Abstract available
     
     
     
124. RAME JE, Pagani FD, Kiernan MS, Oliveira GH, et al
     Evolution of Late Right Heart Failure With Left Ventricular Assist Devices and Association With Outcomes.
     J Am Coll Cardiol. 2021;78:2294-2308.
     PubMed     Abstract available
     
     
     
125. HONIGBERG MC
     Understanding Heart Failure in Women With Preeclampsia: A Call for Prevention.
     J Am Coll Cardiol. 2021;78:2291-2293.
     PubMed    
     
     
     
126. WILLIAMS D, Stout MJ, Rosenbloom JI, Olsen MA, et al
     Preeclampsia Predicts Risk of Hospitalization for Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2281-2290.
     PubMed     Abstract available
     
     
     November 2021
127. GANDHI PU, Windish DM
     Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training.
     J Am Coll Cardiol. 2021;78:2265-2266.
     PubMed    
     
     
     
128. PALAU P, Seller J, Dominguez E, Sastre C, et al
     Effect of beta-Blocker Withdrawal on Functional Capacity in Heart Failure and Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2042-2056.
     PubMed     Abstract available
     
     
     
129. GUAZZI M
     The Link Between Heart Rate, Exercise, and beta-Blocker in HFpEF: Time to Untie the Knot.
     J Am Coll Cardiol. 2021;78:2057-2059.
     PubMed    
     
     
     
130. ZHANG J, Bolli R, Garry DJ, Marban E, et al
     Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:2092-2105.
     PubMed     Abstract available
     
     
     
131. GOTTLIEB SH
     Heart Failure With Reduced Ejection Fraction: "Guideline-Directed Medical Therapy (GDMT)" Versus "The Art of Medicine".
     J Am Coll Cardiol. 2021;78:2013-2016.
     PubMed    
     
     
     
132. RAO VN, Murray E, Butler J, Cooper LB, et al
     In-Hospital Initiation of Sodium-Glucose Cotransporter-2 Inhibitors for Heart Failure With Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;78:2004-2012.
     PubMed     Abstract available
     
     
     
133. KINDEL SJ
     Pediatric Data for Pediatric Heart Failure: Stepping Out on Our Own.
     J Am Coll Cardiol. 2021;78:1901-1903.
     PubMed    
     
     
     
134. PALM J, Holdenrieder S, Hoffmann G, Horer J, et al
     Predicting Major Adverse Cardiovascular Events in Children With Age-Adjusted NT-proBNP.
     J Am Coll Cardiol. 2021;78:1890-1900.
     PubMed     Abstract available
     
     
     
135. AMBARDEKAR AV, Stratton MS, Dobrinskikh E, Hunter KS, et al
     Matrix-Degrading Enzyme Expression and Aortic Fibrosis During Continuous-Flow Left Ventricular Mechanical Support.
     J Am Coll Cardiol. 2021;78:1782-1795.
     PubMed     Abstract available
     
     
     
136. WANNER PM, Wulff DU, Djurdjevic M, Korte W, et al
     Targeting Higher Intraoperative Blood Pressures Does Not Reduce Adverse Cardiovascular Events Following Noncardiac Surgery.
     J Am Coll Cardiol. 2021;78:1753-1764.
     PubMed     Abstract available
     
     
     October 2021
137. KLEINER SHOCHAT M, Fudim M, Kapustin D, Kazatsker M, et al
     Early Impedance-Guided Intervention Improves Long-Term Outcome in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;78:1751-1752.
     PubMed    
     
     
     
138. ESCOBAR-LOPEZ L, Ochoa JP, Mirelis JG, Espinosa MA, et al
     Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy.
     J Am Coll Cardiol. 2021;78:1682-1699.
     PubMed     Abstract available
     
     
     
139. ITOGA NK, Tawfik DS, Montez-Rath ME, Chang TI, et al
     Contributions of Systolic and Diastolic Blood Pressures to Cardiovascular Outcomes in the ALLHAT Study.
     J Am Coll Cardiol. 2021;78:1671-1678.
     PubMed     Abstract available
     
     
     
140. RANGASWAMI J, Lo KB, Vaduganathan M, Mathew RO, et al
     Eligibility for SGLT2 Inhibitors in Heart Failure Without the Race Coefficient for Kidney Function Estimation.
     J Am Coll Cardiol. 2021;78:1669-1670.
     PubMed    
     
     
     
141. SEGAR MW, Khan MS, Patel KV, Butler J, et al
     Prevalence and Prognostic Implications of Diabetes With Cardiomyopathy in Community-Dwelling Adults.
     J Am Coll Cardiol. 2021;78:1587-1598.
     PubMed     Abstract available
     
     
     
142. KENCHAIAH S, Budoff MJ, Ding J, Carr JJ, et al
     Reply: Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
     J Am Coll Cardiol. 2021;78:e113-e115.
     PubMed    
     
     
     
143. BONAPACE S, Molon G, Marinelli A, Lanzoni L, et al
     Prognostic Role of Pericardial Fat on the Incidence of Heart Failure.
     J Am Coll Cardiol. 2021;78:e111.
     PubMed    
     
     
     
144. LEE HH, Lee H, Cho SMJ, Kim DW, et al
     On-Treatment Blood Pressure and Cardiovascular Outcomes in Adults With Hypertension and Left Ventricular Hypertrophy.
     J Am Coll Cardiol. 2021;78:1485-1495.
     PubMed     Abstract available
     
     
     September 2021
145. BOHM M, Anker SD, Butler J, Filippatos G, et al
     Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure.
     J Am Coll Cardiol. 2021;78:1337-1348.
     PubMed     Abstract available
     
     
     
146. CUNNINGHAM JW, Myhre PL
     NT-proBNP Response to Heart Failure Therapies: An Imperfect Surrogate.
     J Am Coll Cardiol. 2021;78:1333-1336.
     PubMed    
     
     
     
147. JANUZZI JL JR, Zannad F, Anker SD, Butler J, et al
     Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial.
     J Am Coll Cardiol. 2021;78:1321-1332.
     PubMed     Abstract available
     
     
     
148. PANDEY A, Shah SJ, Butler J, Kellogg DL Jr, et al
     Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:1166-1187.
     PubMed     Abstract available
     
     
     August 2021
149. FUDIM M, Abraham WT, von Bardeleben RS, Lindenfeld J, et al
     Device Therapy in Chronic Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:931-956.
     PubMed     Abstract available
     
     
     
150. PAGANI FD
     Is Durable Left Ventricular Assist Device Therapy a Viable Option for the Elderly?
     J Am Coll Cardiol. 2021;78:895-897.
     PubMed    
     
     
     
151. EMERSON D, Chikwe J, Catarino P, Hassanein M, et al
     Contemporary Left Ventricular Assist Device Outcomes in an Aging Population: An STS INTERMACS Analysis.
     J Am Coll Cardiol. 2021;78:883-894.
     PubMed     Abstract available
     
     
     
152. HERSBERGER L, Stanga Z, Schuetz P
     Reply: The Importance of Objective Nutritional Indexes in Heart Failure Patients.
     J Am Coll Cardiol. 2021;78:856-857.
     PubMed    
     
     
     
153. IKOMA T, Saito H, Oka T, Maekawa Y, et al
     The Importance of Objective Nutritional Indexes in Heart Failure Patients.
     J Am Coll Cardiol. 2021;78:855-856.
     PubMed    
     
     
     
154. DROZD M, Cubbon RM
     Infection and Adverse Outcomes in People With Chronic Heart Failure: Highlighting a Neglected Problem.
     J Am Coll Cardiol. 2021;78:760.
     PubMed    
     
     
     
155. SHEN L, Jhund PS, McMurray JJV
     Reply: Pneumonia and the Bigger Picture of Infection in Heart Failure.
     J Am Coll Cardiol. 2021;78:760-761.
     PubMed    
     
     
     
156. MEWTON N, Baudry G, Sebbag L
     Pneumonia in Chronic Heart Failure: What About a Full Picture of the Puzzle?
     J Am Coll Cardiol. 2021;78:759.
     PubMed    
     
     
     
157. LEWANDOWSKI AJ, Raman B, Bertagnolli M, Mohamed A, et al
     Association of Preterm Birth With Myocardial Fibrosis and Diastolic Dysfunction in Young Adulthood.
     J Am Coll Cardiol. 2021;78:683-692.
     PubMed     Abstract available
     
     
     
158. CASAS G, Limeres J, Oristrell G, Gutierrez-Garcia L, et al
     Clinical Risk Prediction in Patients With Left Ventricular Myocardial Noncompaction.
     J Am Coll Cardiol. 2021;78:643-662.
     PubMed     Abstract available
     
     
     
159. BROCH K, Anstensrud AK, Woxholt S, Andersen GO, et al
     Reply: Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
     J Am Coll Cardiol. 2021;78:637-638.
     PubMed    
     
     
     
160. DEL BUONO MG, Van Tassell BW, Abbate A
     Clarification Regarding the Lack of Heart Failure Events in the ASSAIL-MI Trial.
     J Am Coll Cardiol. 2021;78:637.
     PubMed    
     
     
     
161. PAVO N, Prausmuller S, Bartko PE, Goliasch G, et al
     Reply: Myocardial Angiotensin Relationships in Heart Failure: Long Way Beyond, Long Way Ahead.
     J Am Coll Cardiol. 2021;78:543-544.
     PubMed    
     
     
     
162. SHCHENDRYGINA A, Mewton N, Meznar AZ
     Advanced Heart Failure and Angiotensin System Fascinating Complexities.
     J Am Coll Cardiol. 2021;78:541-542.
     PubMed    
     
     
     
163. LI L, Wang J, Zhao G, Topaz S, et al
     Percutaneous DLC-Based Total Cavopulmonary Assist Achieves 96-Hour Survival in Lethal Cavopulmonary Failure Sheep.
     J Am Coll Cardiol. 2021;78:538-540.
     PubMed    
     
     
     July 2021
164. ROSSIGNOL P, Pitt B
     Heart Failure and Chronic Kidney Disease Patients: First It Is Necessary to Act.
     J Am Coll Cardiol. 2021;78:344-347.
     PubMed    
     
     
     
165. ITKIN M, Rockson SG, Burkhoff D
     Pathophysiology of the Lymphatic System in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;78:278-290.
     PubMed     Abstract available
     
     
     
166. AMUNDSEN BH
     Atrial Strain: A Piece of the HFpEF Puzzle Found, But Not Yet in Place.
     J Am Coll Cardiol. 2021;78:258-259.
     PubMed    
     
     
     
167. TEERLINK JR, Diaz R, Felker GM, McMurray JJV, et al
     Effect of Ejection Fraction on Clinical Outcomes in Patients Treated With Omecamtiv Mecarbil in GALACTIC-HF.
     J Am Coll Cardiol. 2021;78:97-108.
     PubMed     Abstract available
     
     
     
168. FUDIM M, Salah HM, Sathananthan J, Bernier M, et al
     Lymphatic Dysregulation in Patients With Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;78:66-76.
     PubMed     Abstract available
     
     
     
169. FUSTER JJ
     Clonal Hematopoiesis and Incident Heart Failure Risk: The Clone Wars Reach the Myocardium.
     J Am Coll Cardiol. 2021;78:53-55.
     PubMed    
     
     
     
170. YU B, Roberts MB, Raffield LM, Zekavat SM, et al
     Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure.
     J Am Coll Cardiol. 2021;78:42-52.
     PubMed     Abstract available
     
     
     
171. EIKELBOOM JW, Bhatt DL, Fox KAA, Bosch J, et al
     Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease.
     J Am Coll Cardiol. 2021;78:14-23.
     PubMed     Abstract available
     
     
     June 2021
172. LAM CSP, Solomon SD
     Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:3217-3225.
     PubMed     Abstract available
     
     
     
173. CONDORELLI G, Ferrante G
     MicroRNA-132 Inhibition Prevents Myocardial Hypertrophy and Heart Failure in Pigs: Making Sense Out of Antisense.
     J Am Coll Cardiol. 2021;77:2936-2938.
     PubMed    
     
     
     
174. HINKEL R, Batkai S, Bahr A, Bozoglu T, et al
     AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction.
     J Am Coll Cardiol. 2021;77:2923-2935.
     PubMed     Abstract available
     
     
     
175. JEAN G, Van Mieghem NM, Gegenava T, van Gils L, et al
     Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2021;77:2796-2803.
     PubMed     Abstract available
     
     
     
176. KENCHAIAH S, Ding J, Carr JJ, Allison MA, et al
     Pericardial Fat and the Risk of Heart Failure.
     J Am Coll Cardiol. 2021;77:2638-2652.
     PubMed     Abstract available
     
     
     May 2021
177. PARIKH PB, Bhatt DL, Bhasin V, Anker SD, et al
     Impact of Percutaneous Coronary Intervention on Outcomes in Patients With Heart Failure: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2432-2447.
     PubMed     Abstract available
     
     
     
178. GOTTLIEB SH
     Food and Pharma: Linking 2 Silos of Heart Failure Research and Therapy.
     J Am Coll Cardiol. 2021;77:2320-2322.
     PubMed    
     
     
     
179. HERSBERGER L, Dietz A, Burgler H, Bargetzi A, et al
     Individualized Nutritional Support for Hospitalized Patients With Chronic Heart Failure.
     J Am Coll Cardiol. 2021;77:2307-2319.
     PubMed     Abstract available
     
     
     
180. ALVAREZ-GARCIA J, Jaladanki S, Rivas-Lasarte M, Cagliostro M, et al
     New Heart Failure Diagnoses Among Patients Hospitalized for COVID-19.
     J Am Coll Cardiol. 2021;77:2260-2262.
     PubMed    
     
     
     
181. PATEL RB, Fonarow GC, Greene SJ, Zhang S, et al
     Kidney Function and Outcomes in Patients Hospitalized with Heart Failure.
     J Am Coll Cardiol. 2021 May 4. pii: S0735-1097(21)04968.
     PubMed     Abstract available
     
     
     April 2021
182. MANCINI D, Gibson GT
     Impact of Pneumonia in Heart Failure Patients.
     J Am Coll Cardiol. 2021;77:1974-1976.
     PubMed    
     
     
     
183. SHEN L, Jhund PS, Anand IS, Bhatt AS, et al
     Incidence and Outcomes of Pneumonia in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1961-1973.
     PubMed     Abstract available
     
     
     
184. HONKA H, Solis-Herrera C, Triplitt C, Norton L, et al
     Therapeutic Manipulation of Myocardial Metabolism: JACC State-of-the-Art Review.
     J Am Coll Cardiol. 2021;77:2022-2039.
     PubMed     Abstract available
     
     
     
185. FUDIM M, Neuzil P, Malek F, Engelman ZJ, et al
     Greater Splanchnic Nerve Stimulation in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1952-1953.
     PubMed    
     
     
     
186. SELVARAJ S, Claggett B, Minamisawa M, Windham BG, et al
     Atrial Fibrillation and Ischemic Stroke with the Amyloidogenic V122I Transthyretin Variant among Black Americans.
     J Am Coll Cardiol. 2021 Apr 19. pii: S0735-1097(21)04808.
     PubMed    
     
     
     
187. RAUH MJ
     Impact of Clonal Hematopoiesis in Ischemic and Nonischemic Heart Failure.
     J Am Coll Cardiol. 2021;77:1760-1762.
     PubMed    
     
     
     
188. PASCUAL-FIGAL DA, Bayes-Genis A, Diez-Diez M, Hernandez-Vicente A, et al
     Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1747-1759.
     PubMed     Abstract available
     
     
     
189. PAVO N, Prausmuller S, Spinka G, Goliasch G, et al
     Myocardial Angiotensin Metabolism in End-Stage Heart Failure.
     J Am Coll Cardiol. 2021;77:1731-1743.
     PubMed     Abstract available
     
     
     
190. YAFASOVA A, Fosbol EL, Schou M, Baslund B, et al
     Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
     J Am Coll Cardiol. 2021;77:1717-1727.
     PubMed     Abstract available
     
     
     March 2021
191. BOZKURT B, Fonarow GC, Goldberg LR, Guglin M, et al
     Cardiac Rehabilitation for Patients With Heart Failure: JACC Expert Panel.
     J Am Coll Cardiol. 2021;77:1454-1469.
     PubMed     Abstract available
     
     
     
192. GREENE SJ, Khan MS
     Quadruple Medical Therapy for Heart Failure: Medications Working Together to Provide the Best Care.
     J Am Coll Cardiol. 2021;77:1408-1411.
     PubMed    
     
     
     
193. FERREIRA JP, Zannad F, Pocock SJ, Anker SD, et al
     Interplay of Mineralocorticoid Receptor Antagonists and Empagliflozin in Heart Failure: EMPEROR-Reduced.
     J Am Coll Cardiol. 2021;77:1397-1407.
     PubMed     Abstract available
     
     
     
194. KOSIBOROD MN, Vaduganathan M
     SGLT-2 Inhibitors in Heart Failure: Volume or Value?
     J Am Coll Cardiol. 2021;77:1393-1396.
     PubMed    
     
     
     
195. PACKER M, Anker SD, Butler J, Filippatos G, et al
     Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial.
     J Am Coll Cardiol. 2021;77:1381-1392.
     PubMed     Abstract available
     
     
     
196. VANDERHEYDEN M, Bartunek J, Neskovic AN, Milicic D, et al
     TRVD Therapy in Acute HF: Proof of Concept in Animal Model and Initial Clinical Experience.
     J Am Coll Cardiol. 2021;77:1481-1483.
     PubMed    
     
     
     
197. CHENG RK, Mooney DM, Chien CV, Shah KS, et al
     SGLT2 Inhibitors: Who Should Prescribe Them for Patients With Heart Failure?
     J Am Coll Cardiol. 2021;77:1375-1377.
     PubMed    
     
     
     
198. MCCULLOUGH PA, Rahimi G, Tecson KM
     Ambulatory Worsening of Renal Function in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:1222-1224.
     PubMed    
     
     
     
199. BELDHUIS IE, Myhre PL, Bristow M, Claggett B, et al
     Spironolactone in Patients With Heart Failure, Preserved Ejection Fraction, and Worsening Renal Function.
     J Am Coll Cardiol. 2021;77:1211-1221.
     PubMed     Abstract available
     
     
     
200. BALTHAZAR T, Vandenbriele C, Verbrugge FH, Den Uil C, et al
     Managing Patients With Short-Term Mechanical Circulatory Support: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2021;77:1243-1256.
     PubMed     Abstract available
     
     
     
201. MACK MJ, Lindenfeld J, Abraham WT, Kar S, et al
     3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:1029-1040.
     PubMed     Abstract available
     
     
     
202. KOFOED KF, Engstrom T, Sigvardsen PE, Linde JJ, et al
     Prognostic Value of Coronary CT Angiography in Patients With Non-ST-Segment Elevation Acute Coronary Syndromes.
     J Am Coll Cardiol. 2021;77:1044-1052.
     PubMed     Abstract available
     
     
     February 2021
203. GREENE SJ, Triana TS, Ionescu-Ittu R, Shi S, et al
     Patients Hospitalized for De Novo Versus Worsening Chronic Heart Failure in the United States.
     J Am Coll Cardiol. 2021;77:1023-1025.
     PubMed    
     
     
     
204. FELKER GM, Greene SJ
     Improving In-Hospital Diuretic Therapy for Heart Failure: The Need for High-Quality Evidence.
     J Am Coll Cardiol. 2021;77:709-712.
     PubMed    
     
     
     
205. RAO VS, Ivey-Miranda JB, Cox ZL, Riello R, et al
     Natriuretic Equation to Predict Loop Diuretic Response in Patients With Heart Failure.
     J Am Coll Cardiol. 2021;77:695-708.
     PubMed     Abstract available
     
     
     
206. BERTRAND PB, Overbey JR, Zeng X, Levine RA, et al
     Progression of Tricuspid Regurgitation After Surgery for Ischemic Mitral Regurgitation.
     J Am Coll Cardiol. 2021;77:713-724.
     PubMed     Abstract available
     
     
     
207. GOODLIN SJ
     RESPONSE: Comprehensive Training for Heart Failure Clinicians: The Integration of Palliative Care.
     J Am Coll Cardiol. 2021;77:504-505.
     PubMed    
     
     
     
208. CHUZI S, Khan SS, Pak ES
     Primary Palliative Care Education in Advanced Heart Failure and Transplantation Cardiology Fellowships.
     J Am Coll Cardiol. 2021;77:501-505.
     PubMed    
     
     
     
209. FRISK M, Le C, Shen X, Roe AT, et al
     Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2021;77:405-419.
     PubMed     Abstract available
     
     
     
210. HULOT JS, Livrozet M
     HFpEF: Should We Consider Diabetic Patients Separately?: The Cardiomyocytes Say Yes.
     J Am Coll Cardiol. 2021;77:420-422.
     PubMed    
     
     
     January 2021
211. GOLDBERG LR
     The Pleiotropic Effects of SGLT2 Inhibitors: Remodeling the Treatment of Heart Failure.
     J Am Coll Cardiol. 2021;77:256-258.
     PubMed    
     
     
     
212. WU J, Mamas MA, de Belder MA, Deanfield JE, et al
     Second Decline in Admissions With Heart Failure and Myocardial Infarction During the COVID-19 Pandemic.
     J Am Coll Cardiol. 2021 Jan 12. pii: S0735-1097(20)38196.
     PubMed    
     
     
     
213. MADDOX TM, Januzzi JL Jr, Allen LA, Breathett K, et al
     2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction: A Report of the American College of Cardiology Solution Set Ove
     J Am Coll Cardiol. 2021 Jan 4. pii: S0735-1097(20)37867.
     PubMed    
     
     
     December 2020
214. PAGANI FD
     Extracorporeal Membrane Oxygenation Bridge to Durable Mechanical Circulatory Support: Discerning Futility From Heroic Therapy.
     J Am Coll Cardiol. 2020;76:2965-2967.
     PubMed    
     
     
     
215. ONG G, Pibarot P, Redfors B, Weissman NJ, et al
     Diastolic Function and Clinical Outcomes After Transcatheter Aortic Valve Replacement: PARTNER 2 SAPIEN 3 Registry.
     J Am Coll Cardiol. 2020;76:2940-2951.
     PubMed     Abstract available
     
     
     
216. ALAHMAD B, Khraishah H
     Unconventional Natural Gas Development and Heart Failure: Accumulating Epidemiological Evidence.
     J Am Coll Cardiol. 2020;76:2875-2877.
     PubMed    
     
     
     
217. MCALEXANDER TP, Bandeen-Roche K, Buckley JP, Pollak J, et al
     Unconventional Natural Gas Development and Hospitalization for Heart Failure in Pennsylvania.
     J Am Coll Cardiol. 2020;76:2862-2874.
     PubMed     Abstract available
     
     
     
218. GUPTA DK, Crescenzi R, Aday AW
     Unpreserved Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2830-2833.
     PubMed    
     
     
     
219. ROSSITTO G, Mary S, McAllister C, Neves KB, et al
     Reduced Lymphatic Reserve in Heart Failure With Preserved Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2817-2829.
     PubMed     Abstract available
     
     
     
220. JANUZZI JL JR, Ibrahim NE
     Understanding the Mechanistic Benefit of Heart Failure Drugs Matters.
     J Am Coll Cardiol. 2020;76:2752-2754.
     PubMed    
     
     
     
221. OMAR M, Jensen J, Frederiksen PH, Kistorp C, et al
     Effect of Empagliflozin on Hemodynamics in Patients With Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2020;76:2740-2751.
     PubMed     Abstract available
     
     
     
222. MARON BA, Kovacs G, Vaidya A, Bhatt DL, et al
     Cardiopulmonary Hemodynamics in Pulmonary Hypertension and Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:2671-2681.
     PubMed     Abstract available
     
     
     
223. BEN-YEHUDA O, Shahim B, Chen S, Liu M, et al
     Pulmonary Hypertension in Transcatheter Mitral Valve Repair for Secondary Mitral Regurgitation: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:2595-2606.
     PubMed     Abstract available
     
     
     November 2020
224. BOZKURT B, Hershberger RE, Butler J, Isler ML, et al
     2021 ACC/AHA Key Data Elements and Definitions for Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Data Standards (Writing Committee to Develop Clinical Data Standards for Heart Failure).
     J Am Coll Cardiol. 2020 Nov 26. pii: S0735-1097(20)37777.
     PubMed    
     
     
     
225. ALVAREZ-GARCIA J, Lee S, Gupta A, Cagliostro M, et al
     Prognostic Impact of Prior Heart Failure in Patients Hospitalized With COVID-19.
     J Am Coll Cardiol. 2020;76:2334-2348.
     PubMed     Abstract available
     
     
     
226. FASELIS C, Fonarow GC, Ahmed A
     Reply: Diuretics After Heart Failure Hospitalization, Not for All!
     J Am Coll Cardiol. 2020;76:2418-2420.
     PubMed    
     
     
     
227. DAUW J, Mullens W
     Diuretics After Heart Failure Hospitalization, Not for All!
     J Am Coll Cardiol. 2020;76:2418.
     PubMed    
     
     
     
228. PANJRATH GS, Krepp J
     COVID-19 and Heart Failure: Harsh Reality of Pre-Existing Conditions.
     J Am Coll Cardiol. 2020;76:2349-2351.
     PubMed    
     
     
     
229. CUNNINGHAM JW, Claggett BL, Solomon SD, Zile MR, et al
     Reply: Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
     J Am Coll Cardiol. 2020;76:2417-2418.
     PubMed    
     
     
     
230. LEWIS GA, Schelbert EB, Kadler KE, Miller CA, et al
     Circulating Biomarkers Specific to Myocardial Extracellular Matrix Are Required to Embrace the Heterogeneity of HFpEF.
     J Am Coll Cardiol. 2020;76:2416-2417.
     PubMed    
     
     
     
231. SANTOS-GALLEGO CG, Vargas-Delgado AP, Requena JA, Garcia-Ropero A, et al
     Randomized Trial of Empagliflozin in Non-Diabetic Patients with Heart Failure and Reduced Ejection Fraction.
     J Am Coll Cardiol. 2020 Nov 9. pii: S0735-1097(20)37753.
     PubMed     Abstract available
     
     
     
232. VELAZQUEZ EJ, Reinhardt SW
     Limitations of Natriuretic Peptide Levels in Establishing SGLT-2 Inhibitors for Heart Failure Care.
     J Am Coll Cardiol. 2020;76:2086-2088.
     PubMed    
     
     
     October 2020
233. GIANNONI A, Gentile F, Sciarrone P, Emdin M, et al
     Reply: Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
     J Am Coll Cardiol. 2020;76:2040-2041.
     PubMed    
     
     
     
234. FUDIM M, Soloveva A
     Upright Cheyne-Stokes Respiration in Heart Failure: An Ominous Sign of Cardiovascular Dysregulation.
     J Am Coll Cardiol. 2020;76:2038-2039.
     PubMed    
     
     
     
235. LIU PP, Al-Khalaf M, Blet A
     Time to Reframe Ejection Fraction in Light of New Pathophysiological Insights Into Heart Failure.
     J Am Coll Cardiol. 2020;76:1995-1998.
     PubMed    
     
     
     
236. ADAMO L, Yu J, Rocha-Resende C, Javaheri A, et al
     Proteomic Signatures of Heart Failure in Relation to Left Ventricular Ejection Fraction.
     J Am Coll Cardiol. 2020;76:1982-1994.
     PubMed     Abstract available
     
     
     
237. WHITELAW S, Thabane L, Mamas MA, Reza N, et al
     Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
     J Am Coll Cardiol. 2020;76:1919-1930.
     PubMed     Abstract available
     
     
     
238. HEIDENREICH PA, Fonarow GC, Breathett K, Jurgens CY, et al
     2020 ACC/AHA Clinical Performance and Quality Measures for Adults With Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
     J Am Coll Cardiol. 2020 Oct 27. pii: S0735-1097(20)35968.
     PubMed    
     
     
     
239. KITTLESON MM
     The Trials of Women in Cardiology.
     J Am Coll Cardiol. 2020;76:1931-1933.
     PubMed    
     
     
     
240. EMDIN M, Aimo A, Castiglione V, Vergaro G, et al
     Targeting Cyclic Guanosine Monophosphate to Treat Heart Failure: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:1795-1807.
     PubMed     Abstract available
     
     
     
241. PSOTKA MA, Fiuzat M, Metra M, O'Connor CM, et al
     Reply: Potential Mechanisms to Improve Heart Failure Clinical Trial Publication Rates.
     J Am Coll Cardiol. 2020;76:1717-1718.
     PubMed    
     
     
     
242. MEWTON N, Sebbag L, Bochaton T
     Other Things Behind the Low Rate of Heart Failure Trial Publication.
     J Am Coll Cardiol. 2020;76:1716-1717.
     PubMed    
     
     
     
243. MEHMOOD M
     Low Publication Rates of Heart Failure Clinical Trials: Finding Success in Failure.
     J Am Coll Cardiol. 2020;76:1715-1716.
     PubMed    
     
     
     September 2020
244. KHATANA SAM, Grandin EW, Rame JE, Shen C, et al
     Medicaid Expansion and Ventricular Assist Device Implantation: An Analysis of the INTERMACS Registry.
     J Am Coll Cardiol. 2020;76:1501-1502.
     PubMed    
     
     
     
245. HAHN RT, Asch F, Weissman NJ, Grayburn P, et al
     Impact of Tricuspid Regurgitation on Clinical Outcomes: The COAPT Trial.
     J Am Coll Cardiol. 2020;76:1305-1314.
     PubMed     Abstract available
     
     
     
246. GOTTLIEB SS, Ahmed T
     Consider Everything When Prescribing Sacubitril/Valsartan: Perfection Is the Enemy of Good.
     J Am Coll Cardiol. 2020;76:1049-1050.
     PubMed    
     
     
     
247. GUAZZI M, Ghio S, Adir Y
     Pulmonary Hypertension in HFpEF and HFrEF: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;76:1102-1111.
     PubMed     Abstract available
     
     
     
248. JENTZER JC, Bihorac A, Brusca SB, Del Rio-Pertuz G, et al
     Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives.
     J Am Coll Cardiol. 2020;76:1084-1101.
     PubMed     Abstract available
     
     
     August 2020
249. KAGIYAMA N, Piccirilli M, Yanamala N, Shrestha S, et al
     Machine Learning Assessment of Left Ventricular Diastolic Function Based on Electrocardiographic Features.
     J Am Coll Cardiol. 2020;76:930-941.
     PubMed     Abstract available
     
     
     
250. YAFASOVA A, Fosbol EL, Schou M, Gustafsson F, et al
     Long-Term Adverse Cardiac Outcomes in Patients With Sarcoidosis.
     J Am Coll Cardiol. 2020;76:767-777.
     PubMed     Abstract available
     
     
     
251. COX ZL, Stevenson LW
     The Weight of Evidence for Diuretics and Parachutes.
     J Am Coll Cardiol. 2020;76:680-683.
     PubMed    
     
     
     
252. BAYES-GENIS A, Nunez J, Lupon J
     Sacubitril/Valsartan as Antifibrotic Drug: Rejuvenating the Fibrosed HFpEF Heart.
     J Am Coll Cardiol. 2020;76:515-517.
     PubMed    
     
     
     
253. CUNNINGHAM JW, Claggett BL, O'Meara E, Prescott MF, et al
     Effect of Sacubitril/Valsartan on Biomarkers of Extracellular Matrix Regulation in Patients With HFpEF.
     J Am Coll Cardiol. 2020;76:503-514.
     PubMed     Abstract available
     
     
     July 2020
254. POOLE JE, Olshansky B, Mark DB, Anderson J, et al
     Long-Term Outcomes of Implantable Cardioverter-Defibrillator Therapy in the SCD-HeFT.
     J Am Coll Cardiol. 2020;76:405-415.
     PubMed     Abstract available
     
     
     
255. JANUZZI JL JR, Ibrahim NE
     The Need to Innovate and Accelerate Clinical Trial Performance: BeAT the Clock.
     J Am Coll Cardiol. 2020;76:14-16.
     PubMed    
     
     
     June 2020
256. MEHRA MR, Grazette LP
     Untimely Trial Publication: A Sin of Omission?
     J Am Coll Cardiol. 2020;75:3162-3163.
     PubMed    
     
     
     
257. ROWIN EJ, Maron BJ, Carrick RT, Patel PP, et al
     Outcomes in Patients With Hypertrophic Cardiomyopathy and Left Ventricular Systolic Dysfunction.
     J Am Coll Cardiol. 2020;75:3033-3043.
     PubMed     Abstract available
     
     
     
258. PARKER WF, Chung K, Anderson AS, Siegler M, et al
     Practice Changes at U.S. Transplant Centers After the New Adult Heart Allocation Policy.
     J Am Coll Cardiol. 2020;75:2906-2916.
     PubMed     Abstract available
     
     
     
259. HANNA M, Ruberg FL, Maurer MS, Dispenzieri A, et al
     Cardiac Scintigraphy With Technetium-99m-Labeled Bone-Seeking Tracers for Suspected Amyloidosis: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;75:2851-2862.
     PubMed     Abstract available
     
     
     May 2020
260. YITSHAK-SADE M, Nethery R, Abu Awad Y, Mealli F, et al
     Lowering Air Pollution Levels in Massachusetts May Prevent Cardiovascular Hospital Admissions.
     J Am Coll Cardiol. 2020;75:2642-2644.
     PubMed    
     
     
     
261. MEINERTZ T, Munzel T
     Kansas City Cardiomyopathy Quality Score Indicates Sustained Health Status Improvement in Patients After TMVr.
     J Am Coll Cardiol. 2020;75:2107-2109.
     PubMed    
     
     
     April 2020
262. REDFORS B, Furer A, Selker HP, Thiele H, et al
     Effect of Smoking on Outcomes of Primary PCI in Patients With STEMI.
     J Am Coll Cardiol. 2020;75:1743-1754.
     PubMed     Abstract available
     
     
     March 2020
263. SHAH AM, Cikes M, Zile MR, McMurray JJV, et al
     Reply: Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
     J Am Coll Cardiol. 2020;75:1501-1502.
     PubMed    
     
     
     
264. PALAZZUOLI A, Ruocco G
     Different Phenotype Characterization in PARAGON-HF: An Unresolved Puzzle in Patients With HFpEF.
     J Am Coll Cardiol. 2020;75:1500-1501.
     PubMed    
     
     
     
265. GUGLIN M, Zucker MJ, Borlaug BA, Breen E, et al
     Evaluation for Heart Transplantation and LVAD Implantation: JACC Council Perspectives.
     J Am Coll Cardiol. 2020;75:1471-1487.
     PubMed     Abstract available
     
     
     
266. NIJST P, Martens P, Dauw J, Tang WHW, et al
     Withdrawal of Neurohumoral Blockade After Cardiac Resynchronization Therapy.
     J Am Coll Cardiol. 2020;75:1426-1438.
     PubMed     Abstract available
     
     
     
267. KITZMAN DW, Upadhya B, Felker GM
     A Biomarker Approach to Understanding HFpEF.
     J Am Coll Cardiol. 2020;75:1296-1298.
     PubMed    
     
     
     
268. MARFELLA R, Amarelli C, Cacciatore F, Balestrieri ML, et al
     Lipid Accumulation in Hearts Transplanted From Nondiabetic Donors to Diabetic Recipients.
     J Am Coll Cardiol. 2020;75:1249-1262.
     PubMed     Abstract available
     
     
     
269. NAMBIAR L, LeWinter MM, VanBuren PC, Dauerman HL, et al
     Decade Long Temporal Trends in U.S. Hypertension Related Cardiovascular Mortality.
     J Am Coll Cardiol. 2020 Mar 13. pii: S0735-1097(20)34531.
     PubMed    
     
     
     
270. SABBATINI AR, Kararigas G
     Menopause-Related Estrogen Decrease and the Pathogenesis of HFpEF: JACC Review Topic of the Week.
     J Am Coll Cardiol. 2020;75:1074-1082.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: